Wilson Sonsini advised ImmunityBio, and Goodwin advised the placement agent. ImmunityBio, Inc. (NASDAQ: IBRX) announced that it has executed financing to provide further working capital and support...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
